Screener
Eikon Therapeutics, Inc. EIKN Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Eikon Therapeutics, Inc.’s reported figures.
Plus components not separately reported this period.
The source filing: Eikon Therapeutics, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216791
FAQ
- What is Eikon Therapeutics, Inc.'s total debt?
- Eikon Therapeutics, Inc. (EIKN) reported total debt of $254.83M in Q1 2026.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Eikon Therapeutics, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude